<DOC>
	<DOCNO>NCT00102947</DOCNO>
	<brief_summary>This Phase 4 , randomize , open-label , multicenter , comparative study design evaluate pharmacokinetics intravenous ( i.v . ) daptomycin safety efficacy daptomycin relative comparator treatment complicate skin skin structure infection patient renal impairment .</brief_summary>
	<brief_title>Daptomycin Treatment Patients With Renal Insufficiency Complicated Skin Skin Structure Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Soft Tissue Infections</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Moderate endstage renal impairment A diagnosis complicate skin skin structure infection know suspect due susceptible Grampositive bacteria base positive Gram stain A diagnosis bacterial skin skin structure infection presence complicate factor Known bacteremia , osteomyelitis endocarditis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>renal impairment</keyword>
	<keyword>daptomycin</keyword>
	<keyword>Cubist</keyword>
	<keyword>complicate skin skin structure infection</keyword>
</DOC>